Yi Lin
Direttore/Membro del Consiglio presso Suzhou PANOMIX Biomedical Tech Co., Ltd.
Provenienza dei contatti di primo grado di Yi Lin
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Suzhou PANOMIX Biomedical Tech Co., Ltd.
 Suzhou PANOMIX Biomedical Tech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Panomik Biomedical Technology Co. Ltd. provides metabolomics testing and analysis services. The company is located in China.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Yi Lin tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
 Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Part of Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd is a company that manufactures and distributes therapeutics for cancer treatment. Jiangsu Alphamab Biopharmaceuticals Co., Ltd is based in Suzhou, China. The Chinese company was founded in 2015 by Ting Xu. Ting Xu has been the CEO since 2015. | Pharmaceuticals: Major | Chief Executive Officer | |
| Jiangnan University | College/University | Graduate Degree | |
| Chinese Academy of Sciences | College/University | Doctorate Degree | |
| Nanjing University | College/University | Undergraduate Degree | |
| Suzhou Oncoimmune Co. Ltd. | Director/Board Member | ||
| Shanghai Kangjing Bioscience Co. Ltd. | Director/Board Member | ||
| Suzhou Bionovogene Biotech Co. Ltd. | Director/Board Member | ||
Suzhou SmartNuclide Biopharmaceutical Co., Ltd.
 Suzhou SmartNuclide Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Suzhou SmartNuclide Biopharmaceutical Co. Ltd. develops and manufactures radiopharmaceuticals. The company is based in Suzhou, China. | Biotechnology | Founder | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALPHAMAB ONCOLOGY | Biotechnology | Chief Executive Officer | |
Suzhou Industrial Park Biotech Development Co. Ltd.
 Suzhou Industrial Park Biotech Development Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Industrial Park Biotech Development Co. Ltd. operates as a Chinese biotechnology company. The private company is located in China. | Miscellaneous Commercial Services | President | |
Suzhou Alphamab Co., Ltd.
 Suzhou Alphamab Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Alphamab Co. Ltd. operates as biotechnology company. It offers antibody screening, pharmacodynamics and protein/Ab engineering. The company was founded by Ting Xu in 2009 and is headquartered in Suzhou, China. | Miscellaneous Commercial Services | Founder | |
| HANGZHOU TIGERMED CONSULTING CO., LTD | Miscellaneous Commercial Services | Director/Board Member | |
| Bohe Angel Fund | Investment Managers | Corporate Officer/Principal | |
MEDx Translational Medicine Co., Ltd.
 MEDx Translational Medicine Co., Ltd. Medical DistributorsDistribution Services MEDx Translational Medicine Co., Ltd. is a leading Chinese innovative company in companion diagnostics and precision medicine in China. The company is based in Suzhou, China. MEDx collaborates with hundreds of world-renowned pharmaceutical companies and has been rewarded with many certifications, including China CNAS, ISO17025, and US CAP ISO 13485, among others. The company was founded in 2013 as Qiagen Translational Medicine Co., Ltd. With comprehensive technology platforms, high-quality systems, and strong IVD R&D experience, MEDx offers integrated solutions from biomarker discovery to patient stratification for drug clinical trials, IVD/CDX R&D, and commercialization. The company was founded in 2013 by Ya Fei Zhang, who has been the CEO since then. | Medical Distributors | Director/Board Member | |
| BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| BI Norwegian Business School | College/University | Graduate Degree | |
| Fudan University | College/University | Graduate Degree | |
| China Pharmaceutical University | College/University | Graduate Degree | |
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member | |
| Shanghai Jiao Tong University | College/University | Graduate Degree |
Statistiche
Distribuzione geografica
| Cina | 20 |
| Isole Cayman | 2 |
| Stati Uniti | 2 |
| Norvegia | 2 |
Settori
| Health Technology | 8 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Finance | 2 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 14 |
| Chairman | 6 |
| Graduate Degree | 6 |
| Founder | 5 |
| Chief Executive Officer | 4 |
Contatti più connessi
| Insiders | |
|---|---|
| Yu Wen Liu | 11 |
| Ting Xu | 11 |
| Jian Hong Ren | 2 |
| Zheng Cao | 2 |
- Borsa valori
- Insiders
- Yi Lin
- Connessioni Società
